The main aim of the Journal of AIDS & Clinical Research (JAR) is to publish high quality research works and provide Open Access to the articles using this platform. The Journal offers a rapid and time bound review and publication that freely disseminates research findings related to AIDS & Clinical research. Journal of AIDS & Clinical Research caters to the requirements of the medical practitioners, behavior therapists, researchers, lab professionals, students, academicians, and industry that are involved in Medical and Pharmaceutical studies. No matter how prestigious or popular; it increases the visibility and impact of published work. It increases convenience, reach, and retrieval power.
Journal of AIDS & Clinical Research (JAR) welcomes the submission of manuscripts on Innovative HIV drugs, Advances in HIV Medications, Highly Active Antiretroviral Therapy, Risk Analysis: HIV, etc. that meet the general criteria of significance and scientific excellence. Free online literature software facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis.
All works published by Hilaris SRL are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Journal of AIDS & Clinical Research strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. JAR will keep up-to- date with latest advances in the field of AIDS & Clinical Research. Abstracts and full texts (HTML, PDF and XML format) of all articles published by JAR are freely accessible to everyone immediately after publication. Journal of AIDS & Clinical Research supports the Bethesda Statement on Open Access Publishing.